US Physical Therapy (NYSE: USPH) reported Q2 EPS of $0.47, $0.35 worse than the analyst estimate of $0.82. Revenue for the quarter came in at $167.19 million versus the consensus estimate of $163.34 million.

MANAGEMENT UPDATES 2024 EARNINGS GUIDANCE

Management returned its guidance for Adjusted EBITDA for 2024 to its original range of $80.0 million to $85.0 million. The change in guidance reflects the lingering tough employment environment for both clinical and front office staff which has resulted in greater costs than anticipated in both salaries and contract labor so far this year.

For earnings history and earnings-related data on US Physical Therapy (USPH) click here.